Urinary NGAL concentrations at baseline did not differ among patients with no/mild AKI (1.7 ng/ml, IQR 0.7–3) and those with severe AKI (1.3 ng/ml, IQR 0.8–2.8, P = 0.99; “Fig 2B”). The gene discussed is LCN2; the disease is acute kidney injury.